[Inhibition of thrombocyte aggregation by antioxidants]

Biull Eksp Biol Med. 1986 Mar;101(3):337-9.
[Article in Russian]

Abstract

The effects of antioxidants (3-hydroxypyridines, 5-hydroxypyrimidines, hindered phenols) on platelet aggregation were studied. All the compounds under study possessed low anti-aggregation activity against indometacin-sensitive aggregation (activation with arachidonic acid, 50 M). Half-maximal inhibition of aggregation was achieved at a concentration similar to that of the compounds used (10(-3) M in cases of indomethacin-insensitive aggregation, platelet activation by thrombine 1.5 mu/ml and Ca2+-ionophore A23187 1.5 g/ml). 4-methyl-2.6-ditretbutyl phenol (BHT) in the concentration range of 10(-5)-4 X 10(-5) M inhibited and in the concentration range of 4 X 10(-5)-10(-4) M activated indomethacin-sensitive aggregation. The latter effect was not observed in the absence of Ca2+ ions in the incubation medium. It is concluded that the effects of the antioxidants studied on platelet aggregation were due to their non-specific action on platelet membranes.

Publication types

  • Comparative Study
  • English Abstract

MeSH terms

  • Antioxidants / pharmacology*
  • Blood Platelets / drug effects
  • Blood Platelets / enzymology
  • Cyclooxygenase Inhibitors
  • Depression, Chemical
  • Dose-Response Relationship, Drug
  • Humans
  • Platelet Aggregation / drug effects*

Substances

  • Antioxidants
  • Cyclooxygenase Inhibitors